Results 41 to 50 of about 4,254,676 (261)
Survey on adverse events associated with drug therapy for breast cancer patients
Background In the breast cancer treatment, there may be a gap between patients’ information needs and physicians’ perceptions. To address this issue, we conducted a comprehensive questionnaire survey aimed to assess the specific information needs of ...
Fumikata Hara +8 more
doaj +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
Background:. Although skin cancer survivors have an increased risk of future malignancies, many are unaware of this and may not undergo preventative screening. Objective:. To evaluate skin cancer survivors’ prevalence of breast, colorectal, cervical, and
Sarah A. Mullen Keffer, MD +2 more
doaj +1 more source
Fear of cancer recurrence and social support among indonesian gynecological cancer survivors [PDF]
Background: Fear of cancer recurrence is a long-term psychological problem of the cancer survivors regardless of the type of cancer. A growing number of studies had addressed fear of cancer recurrence, yet they are largely focused on the breast cancer ...
Wijayanti Tri +3 more
doaj
Quality of Life and Its Association with Physical Activity among Different Types of Cancer Survivors. [PDF]
The main goal of this study was to compare the quality of life (QOL) and its association with physical activity (PA) among patients diagnosed with different types of cancer.
Furong Tang +5 more
doaj +1 more source
Introduction Follow-up care is important for gastric cancer survivors, but follow-up strategies for gastric cancer survivors remain inconsistent, and compliance of gastric cancer survivors with follow-up care is very low.
Hui Xue +5 more
doaj +1 more source
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann +8 more
wiley +1 more source
Introduction Around 25% of the global population faces cancer in their lifetime, with many older cancer survivors enduring lasting treatment effects and risk of recurrence, which negatively impacts their subjective health experience.
Damien S. E. Broekharst +4 more
doaj +1 more source
Cancer Survivors in Delaware: Impact of Comorbidity
Introduction Delaware’s recent longevity and aging trends predict a continual increase in the number of cancer survivors. As the cancer survivors live longer and age, the prevalence of comorbid chronic conditions tends to increase.
S. Gupta
doaj +1 more source
Background Cancer is a leading cause of death among people 15–24 years of age. Increasing numbers of cancer patients survive. Extensive cancer therapy may cause wide‐ranging somatic and psychosocial challenges in the lives of the survivors.
Kristine Hjulstad +3 more
doaj +1 more source

